TScan Therapeutics TCRX Price Prediction

The determination to procure TScan Therapeutics is entirely contingent on your individualistic risk tolerance. As you may discern, TScan Therapeutics's value has experienced an escalation of 3.31% during the preceding 24 hours, and TScan Therapeutics has incurred a decline of -47.54% over the prior 30-day duration. Consequently, the determination of whether or not to invest in TScan Therapeutics will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of TScan Therapeutics may potentially surge to $1.07 by the end of this year. Looking at TScan Therapeutics's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $1.22. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental TScan Therapeutics forecast, the price of TScan Therapeutics will increase by 2.02% over the next week and reach $1.02 by November 25, 2025.

Based on the our new experimental TScan Therapeutics forecast, the price of TScan Therapeutics will increase by 2.65% over the next month and reach $1.03 by December 18, 2025.

As per our most recent prediction on TScan Therapeutics's value in 2025, TCRX is anticipated to fluctuate within the range of $1.00 and $1.07. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected TScan Therapeutics price forecast fails to consider sudden and extreme price fluctuations.

TScan Therapeutics's future appears to be on an upward trend, with an maximum price of $1.22 projected after a period of five years. Based on the TScan Therapeutics forecast for 2030, TScan Therapeutics's value may potentially reach its highest peak of approximately $1.22, while its lowest peak is anticipated to be around $1.03.

Based on the our new experimental TScan Therapeutics price prediction simulation, TCRX’s value in 2025 expected to grow by 7.35% to $1.07 if the best happened. The price will be between $1.07 and $1.00 during 2025.

According to our latest experimental simulation for TScan Therapeutics price prediction, TCRX’s value could rise by 28.11% to $1.28 in 2026, assuming the most favorable conditions. The price is projected to fluctuate between $1.28 and $1.07 throughout the year.

Our new experimental TScan Therapeutics price prediction model suggests that TCRX’s value in 2027 could increase by 33% , reaching $1.33 in the best-case scenario. The price is expected to range between $1.33 and $1.15 during the year.

Based on our experimental forecast model, TScan Therapeutics's value may experience a 20.07% growth in 2028, potentially reaching $1.20 under optimal conditions. The predicted price range for 2028 lies between $1.20 and $0.97.

Using our new experimental simulation for TScan Therapeutics price predictions, TCRX’s value in 2029 is expected to rise by 10.06% , reaching $1.10 in the best scenario. The price is forecasted to range between $1.10 and $0.97 over the course of 2029.

Our experimental simulation indicates that TScan Therapeutics’s price could grow by 22.69% in 2030, potentially hitting $1.22 under ideal conditions. The price will likely fluctuate between $1.22 and $1.03 during the year.

Based on the findings from our latest experimental TScan Therapeutics price prediction, TCRX could see a 26.92% rise in value, reaching $1.27 if the most positive scenario plays out in 2031. The price is expected to stay within a range of $1.27 and $1.17 throughout the year.

According to our experimental TScan Therapeutics price prediction, TCRX’s value is anticipated to rise by 41.43% in 2032, with the highest potential price being $1.41. Throughout the year, TCRX’s price could range from $1.41 and $1.24.

The results from our new TScan Therapeutics price prediction simulation suggest that TCRX may rise by 62.85% in 2033, potentially reaching $1.63 under the best circumstances. The predicted price range for the year is between $1.63 and $1.42.

Based on our experimental forecast for TScan Therapeutics’s price, TCRX could grow by 78.7% , with the value potentially hitting $1.79 in 2034. The expected price range for the year lies between $1.79 and $1.58.

Our recent TScan Therapeutics price prediction simulation suggests that TCRX’s value might rise by 104.98% in 2035, possibly reaching $2.05 if conditions are optimal. The expected price range for 2035 is between $2.05 and $1.72.

According to the experimental simulation, TScan Therapeutics’s value could rise by 152.82% in 2036, with a high of $2.53 under favorable conditions. The price is expected to fall between $2.53 and $1.98 over the course of the year.